Behrens A, Beckmann M, Stübs F (2023)
Publication Type: Journal article
Publication year: 2023
Book Volume: 50
Pages Range: 373-385
Journal Issue: 3
The statutory cancer screening program (GKFP) covers regulations for early detection and screening of cancer for men and women in Germany. Costs for these assessments are covered by the health insurance. The G-BA is in charge of the organized screening, in which women between 20 and 34 years of age are entitled to a yearly screening assessment based on cytology smears. Women of 35 years and older are offered a combination of HPV testing and cytology every 3 years. Data showed a reduced incidence of invasive carcinoma of the cervix as well as of precancerous lesions and overall mortality. Participation in screening assessments for cervical cancer is recommended independently of HPV vaccination status for all women in the according age range. Prophylactic vaccination against HPV high risk types are recommended for all children and adolescents independently of the gender between 9–14 years of age, but before the first sexual intercourse. However, the license according to the European Medicines Agency (EMA) covers all children irrespective of the gender starting at 9 years of age without defining an upper age limit. At the moment, two HPV vaccines are available. For both vaccines, a 2-dose-vaccination regimen is recommended. HPV vaccination can also be valuable for adolescents and adults older than 17 years and to reduce reinfection rates after HPV infection. In this case, HPV vaccination is solely a prophylactic measure and has no therapeutic effect.
APA:
Behrens, A., Beckmann, M., & Stübs, F. (2023). Aktuelles zum gesetzlichen Früherkennungsprogramm des Zervixkarzinoms in Deutschland. gynäkologische praxis, 50(3), 373-385.
MLA:
Behrens, Annika, Matthias Beckmann, and Frederik Stübs. "Aktuelles zum gesetzlichen Früherkennungsprogramm des Zervixkarzinoms in Deutschland." gynäkologische praxis 50.3 (2023): 373-385.
BibTeX: Download